Security
Prestige Consumer Healthcare Inc. · PBH
PBHNYSECommon stockCurrentCIK 1295947Updated Oct 6, 2026
Name history
Prestige Brands Holdings, Inc. · through Aug 10, 2018
PBH price & chart
Loading TradingView…
NYSE:PBH on TradingView ↗About the company
Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Breathe Right® nasal strips, Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® and TheraTears® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.
In the news
Prestige Consumer Healthcare Inc. to Participate in Canaccord Genuity Annual Growth Conference ↗
PBH Investors Have Opportunity to Join Prestige Consumer Healthcare Inc. Fraud Investigation with the Schall Law Firm ↗
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc. - PBH ↗
Recent filings
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
10-Q filing
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
4 filing
4 filing
Show 5 more recent filings
4 filing
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Items 1.01, 2.03, 9.01
Financial Statements and Exhibits
Items 9.01
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Regulation FD Disclosure
Items 1.01, 2.03, 7.01, 9.01
Financial Statements and Exhibits
Items 9.01
Financials
FY 2026 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2026 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2027 | Q1 2026 | Q1 2025 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 3,494,743,000Source | 3,329,497,000Source | 3,339,753,000Source | 3,442,280,000Source | 3,316,885,000Source | 4,568,573,000Source | 3,431,625,000Source | 3,307,516,000Source | 3,494,313,000Source | 3,402,218,000Source | 3,318,417,000Source | 3,353,729,000Source |
| Property, Plant and Equipment, NetUSD | 128,214,000Source | 73,524,000Source | 70,356,000Source | 73,100,000Source | 74,920,000Source | 117,178,000Source | 73,786,000Source | 75,409,000Source | 121,689,000Source | 74,548,000Source | 76,507,000Source | 70,412,000Source |
| GoodwillUSD | 581,248,000Source | 527,219,000Source | 527,878,000Source | 528,411,000Source | 529,225,000Source | 650,795,000Source | 528,314,000Source | 528,443,000Source | 581,109,000Source | 527,425,000Source | 527,733,000Source | 527,553,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 2,301,536,000Source | 2,310,650,000Source | 2,328,529,000Source | 2,291,073,000Source | 2,316,542,000Source | 3,243,358,000Source | 2,294,829,000Source | 2,317,817,000Source | 2,299,605,000Source | 2,295,350,000Source | 2,320,583,000Source | 2,341,893,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 62,373,000Source | 50,874,000Source | 63,615,000Source | 119,106,000Source | 51,540,000Source | 89,127,000Source | 139,502,000Source | 34,256,000Source | 63,868,000Source | 97,884,000Source | 46,469,000Source | 58,489,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 190,456,000Source | 167,274,000Source | 174,288,000Source | 199,000,000Source | 163,547,000Source | 187,355,000Source | 168,405,000Source | 171,695,000Source | 191,920,000Source | 194,293,000Source | 176,775,000Source | 167,016,000Source |
| Inventory, NetUSD | 163,594,000Source | 151,516,000Source | 148,637,000Source | 158,996,000Source | 156,225,000Source | 190,215,000Source | 153,126,000Source | 152,040,000Source | 159,132,000Source | 147,709,000Source | 138,717,000Source | 162,121,000Source |
| Assets, CurrentUSD | 433,428,000Source | 377,164,000Source | 393,786,000Source | 497,411,000Source | 380,708,000Source | 496,814,000Source | 480,518,000Source | 368,741,000Source | 431,484,000Source | 448,328,000Source | 375,043,000Source | 391,743,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 17,005,000Source | 7,500,000Source | 7,246,000Source | 20,309,000Source | 9,396,000Source | 30,117,000Source | 19,485,000Source | 10,750,000Source | 16,564,000Source | 8,442,000Source | 13,082,000Source | 4,117,000Source |
| Operating Lease, Right-of-Use AssetUSD | 23,928,000Source | 29,658,000Source | 10,695,000Source | 25,427,000Source | 8,551,000Source | 26,040,000Source | 26,918,000Source | 9,997,000Source | 27,780,000Source | 28,238,000Source | 11,285,000Source | 14,923,000Source |
| Other Assets, NoncurrentUSD | 3,793,000Source | 6,339,000Source | 6,303,000Source | 3,442,000Source | 6,727,000Source | 13,432,000Source | 3,024,000Source | 6,232,000Source | 10,870,000Source | 3,273,000Source | 5,725,000Source | 3,005,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 1,665,292,000Source | 1,541,064,000Source | 1,739,176,000Source | 1,617,311,000Source | 1,585,124,000Source | 2,651,857,000Source | 1,576,143,000Source | 1,626,749,000Source | 1,606,797,000Source | 1,567,321,000Source | 1,663,333,000Source | 1,906,645,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 562,000Source | 559,000Source | 553,000Source | 562,000Source | 557,000Source | 563,000Source | 561,000Source | 557,000Source | 562,000Source | 560,000Source | 555,000Source | 548,000Source |
| Additional Paid in CapitalUSD | 605,495,000Source | 588,207,000Source | 556,452,000Source | 602,756,000Source | 576,596,000Source | 612,513,000Source | 600,238,000Source | 572,846,000Source | 608,520,000Source | 593,402,000Source | 567,448,000Source | 535,356,000Source |
| Retained Earnings (Accumulated Deficit)USD | 1,692,175,000Source | 1,505,674,000Source | 1,291,739,000Source | 1,645,479,000Source | 1,444,642,000Source | 1,775,280,000Source | 1,603,268,000Source | 1,390,265,000Source | 1,746,103,000Source | 1,555,802,000Source | 1,341,197,000Source | 1,131,858,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -30,234,000Source | -40,164,000Source | -28,529,000Source | -31,600,000Source | -26,536,000Source | -29,678,000Source | -32,255,000Source | -31,335,000Source | -28,368,000Source | -37,659,000Source | -34,495,000Source | -31,564,000Source |
| Stockholders' Equity Attributable to ParentUSD | 1,829,451,000Source | 1,788,433,000Source | 1,600,577,000Source | 1,824,969,000Source | 1,731,761,000Source | 1,916,716,000Source | 1,855,482,000Source | 1,680,767,000Source | 1,887,516,000Source | 1,834,897,000Source | 1,655,084,000Source | 1,447,084,000Source |
| Liabilities and EquityUSD | 3,494,743,000Source | 3,329,497,000Source | 3,339,753,000Source | 3,442,280,000Source | 3,316,885,000Source | 4,568,573,000Source | 3,431,625,000Source | 3,307,516,000Source | 3,494,313,000Source | 3,402,218,000Source | 3,318,417,000Source | 3,353,729,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 139,557,000Source | 102,545,000Source | 127,437,000Source | 134,604,000Source | 106,906,000Source | 153,806,000Source | 109,668,000Source | 114,115,000Source | 120,924,000Source | 106,623,000Source | 117,048,000Source | 160,715,000Source |
| Operating Lease, Liability, CurrentUSD | 6,019,000Source | 6,018,000Source | 5,650,000Source | 6,048,000Source | 2,560,000Source | 7,010,000Source | 6,072,000Source | 3,654,000Source | 6,910,000Source | 6,047,000Source | 4,658,000Source | 6,926,000Source |
| Accounts Payable, CurrentUSD | 42,946,000Source | 19,506,000Source | 39,339,000Source | 41,924,000Source | 31,172,000Source | 36,849,000Source | 22,206,000Source | 39,556,000Source | 22,791,000Source | 18,925,000Source | 38,979,000Source | 62,743,000Source |
| Operating Lease, Liability, NoncurrentUSD | 18,458,000Source | 24,168,000Source | 6,138,000Source | 19,939,000Source | 6,517,000Source | 19,129,000Source | 21,397,000Source | 7,055,000Source | 20,955,000Source | 22,732,000Source | 7,528,000Source | 9,876,000Source |
| Deferred Income Tax Liabilities, NetUSD | 449,331,000Source | 413,276,000Source | 397,147,000Source | 444,924,000Source | 414,865,000Source | 448,824,000Source | 426,947,000Source | 409,085,000Source | 447,417,000Source | 419,594,000Source | 403,596,000Source | 380,434,000Source |
| Other Liabilities, NoncurrentUSD | 5,747,000Source | 5,029,000Source | 8,919,000Source | 5,379,000Source | 5,124,000Source | 5,587,000Source | 5,406,000Source | 5,138,000Source | 5,580,000Source | 5,391,000Source | 9,185,000Source | 8,165,000Source |
| Additional Financial Items | ||||||||||||
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 438,760,000Source | 418,757,000Source | 401,181,000Source | 378,523,000Source |
| Long-term DebtUSD | — | — | — | — | — | — | — | — | 993,953,000Source | 992,357,000Source | 1,125,804,000Source | 1,345,788,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | — | 1,000,000,000Source | 1,210,000,000Source | — | 1,060,000,000Source | 2,007,235,000Source | — | 1,100,000,000Source | — | — | 1,125,804,000Source | 1,345,788,000Source |
| Long-term Debt, Current Maturities | — | — | — | — | — | —Source | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2026 | Q4 2025 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2027 | Q1 2026 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 8,753,000Source | 7,666,000Source | 31,273,000Source | 30,173,000Source | 30,675,000Source | 32,625,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 3,994,000Source | 3,682,000Source | 10,835,000Source | 11,157,000Source | — | — |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -3,450,000Source | -27,343,000Source | 3,685,000Source | 16,327,000Source | 6,322,000Source | 24,927,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 2,828,000Source | 4,441,000Source | 1,597,000Source | 9,314,000Source | -24,439,000Source | 42,225,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 13,403,000Source | 2,756,000Source | -151,000Source | -19,411,000Source | -24,971,000Source | 7,258,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | 193,000Source | 5,827,000Source | 22,697,000Source | 14,409,000Source | 23,070,000Source | -60,765,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 70,788,000Source | 79,013,000Source | 257,627,000Source | 251,515,000Source | 248,926,000Source | 229,716,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | 1,045,000,000Source | 0Source | 123,736,000Source | — | — | 0Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -1,063,737,000Source | -1,938,000Source | -136,841,000Source | -17,452,000Source | -20,111,000Source | -11,584,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | — | — | — | — | — | — | — | 1,100,000Source | 1,927,000Source | — | — | 3,800,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 3,703,000Source | 838,000Source | 11,178,000Source | 8,224,000Source | 9,550,000Source | 7,784,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | 2,661,000Source | 4,054,000Source | 4,322,000Source | 5,832,000Source | 5,508,000Source | 5,466,000Source |
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | 0Source | 34,775,000Source | 156,283,000Source | 51,509,000Source | 25,000,000Source | 50,000,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 1,018,454,000Source | -36,282,000Source | -156,062,000Source | -182,075,000Source | -241,015,000Source | -185,846,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | — | — | — | — | — | — | -1,486,000Source | 0Source | -246,000Source | — | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 25,259,000Source | 41,618,000Source | -34,016,000Source | 51,415,000Source | -12,020,000Source | 31,304,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 62,373,000Source | 50,874,000Source | 119,106,000Source | 51,540,000Source | 89,127,000Source | 139,502,000Source | 63,868,000Source | 97,884,000Source | 46,469,000Source | 58,489,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 11,379,000Source | 11,501,000Source | 43,843,000Source | 47,804,000Source | 63,248,000Source | 54,243,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 45,944,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | -246,000Source | 825,000Source | 1,260,000Source | -573,000Source | 180,000Source | -982,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 2,739,000Source | 2,865,000Source | 1,767,000Source | 2,134,000Source | 3,994,000Source | 3,682,000Source | 10,835,000Source | 11,157,000Source | 14,010,000Source | 12,405,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | — | — | — | 465,000Source | 442,000Source | 1,797,000Source | 1,754,000Source | 5,240,000Source | 4,364,000Source |
| Amortization of Intangible AssetsUSD | — | — | 4,400,000Source | 4,200,000Source | 4,500,000Source | 4,800,000Source | 4,926,000Source | 4,500,000Source | 17,919,000Source | 18,263,000Source | 19,784,000Source | 22,266,000Source |
| DepreciationUSD | — | — | — | — | — | — | — | — | 10,100,000Source | 9,700,000Source | 8,200,000Source | 7,700,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | -191,000Source | 0Source | -165,000Source | -234,000Source | -274,000Source | -273,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 0Source |
| General and Administrative ExpenseUSD | — | — | 29,674,000Source | 26,182,000Source | 28,037,000Source | 26,067,000Source | 43,303,000Source | 28,456,000Source | 116,447,000Source | 108,209,000Source | 106,152,000Source | 107,354,000Source |
| GoodwillUSD | — | — | 581,248,000Source | 527,219,000Source | 528,411,000Source | 529,225,000Source | 650,795,000Source | 528,314,000Source | 581,109,000Source | 527,425,000Source | 527,733,000Source | 527,553,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | — | — | — | — | — | 0Source | 12,466,000Source | 0Source | 370,217,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | — | 48,805,000Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | — | 12,466,000Source | — | 321,412,000Source |
| Income Tax Expense (Benefit)USD | — | — | 15,118,000Source | 19,122,000Source | 26,922,000Source | 17,286,000Source | 9,364,000Source | 14,311,000Source | 67,195,000Source | 69,584,000Source | 66,686,000Source | -11,609,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 46,696,000Source | 61,032,000Source | 42,211,000Source | 54,377,000Source | 29,177,000Source | 47,466,000Source | 190,301,000Source | 214,605,000Source | 209,339,000Source | -82,306,000Source |
| Operating ExpensesUSD | — | — | 74,878,000Source | 69,087,000Source | 71,909,000Source | 73,043,000Source | 83,668,000Source | 68,575,000Source | 286,169,000Source | 297,688,000Source | 282,019,000Source | 647,709,000Source |
| Other Depreciation and AmortizationUSD | — | — | 5,149,000Source | 4,960,000Source | 5,171,000Source | 5,567,000Source | 5,697,000Source | 5,182,000Source | 20,940,000Source | 21,290,000Source | 22,552,000Source | 25,077,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -10,005,000Source | -353,000Source | -501,000Source | -395,000Source | -34,000Source | 224,000Source | -9,574,000Source | -4,954,000Source | 756,000Source | -2,336,000Source |
| Payments of Financing CostsUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 769,000Source | 0Source |
| Proceeds from Stock Options ExercisedUSD | — | — | 0Source | 8,748,000Source | 752,000Source | 1,617,000Source | 0Source | 3,155,000Source | 4,285,000Source | 14,802,000Source | 18,089,000Source | 7,372,000Source |
| Provision for Loan, Lease, and Other LossesUSD | — | — | — | — | — | — | — | — | 10,332,000Source | — | — | — |
| Proceeds from Issuance of Long-term Debt | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2026 | Q4 2025 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2027 | Q1 2026 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 283,444,000Source | 290,317,000Source | 274,114,000Source | 283,785,000Source | 265,710,000Source | 249,530,000Source | 1,088,705,000Source | 1,137,762,000Source | 1,125,357,000Source | 1,127,725,000Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Operating Income (Loss)USD | — | — | 82,491,000Source | 91,962,000Source | 79,670,000Source | 84,339,000Source | 52,520,000Source | 71,756,000Source | 309,409,000Source | 336,775,000Source | 342,429,000Source | -22,415,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -10,005,000Source | -353,000Source | -501,000Source | -395,000Source | -34,000Source | 224,000Source | -9,574,000Source | -4,954,000Source | 756,000Source | -2,336,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | 257,496,000Source | 284,189,000Source | 276,025,000Source | -93,915,000Source |
| Income Tax Expense (Benefit)USD | — | — | 15,118,000Source | 19,122,000Source | 26,922,000Source | 17,286,000Source | 9,364,000Source | 14,311,000Source | 67,195,000Source | 69,584,000Source | 66,686,000Source | -11,609,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 46,696,000Source | 61,032,000Source | 42,211,000Source | 54,377,000Source | 29,177,000Source | 47,466,000Source | 190,301,000Source | 214,605,000Source | 209,339,000Source | -82,306,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 0.98Source | 1.23Source | 0.86Source | 1.1Source | 0.61Source | 0.96Source | 3.93Source | 4.32Source | 4.21Source | -1.65Source |
| Earnings Per Share, DilutedUSD per share | — | — | 0.97Source | 1.22Source | 0.86Source | 1.09Source | 0.61Source | 0.95Source | 3.91Source | 4.29Source | 4.17Source | -1.65Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 47,880,000Source | 49,597,000Source | 49,025,000Source | 49,652,000Source | 47,462,000Source | 49,475,000Source | 48,456,000Source | 49,697,000Source | 49,757,000Source | 49,889,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 48,087,000Source | 49,993,000Source | 49,264,000Source | 49,998,000Source | 47,604,000Source | 49,833,000Source | 48,720,000Source | 50,080,000Source | 50,178,000Source | 49,889,000Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 4,400,000Source | 4,200,000Source | 4,500,000Source | 4,800,000Source | 4,926,000Source | 4,500,000Source | 17,919,000Source | 18,263,000Source | 19,784,000Source | 22,266,000Source |
| General and Administrative ExpenseUSD | — | — | 29,674,000Source | 26,182,000Source | 28,037,000Source | 26,067,000Source | 43,303,000Source | 28,456,000Source | 116,447,000Source | 108,209,000Source | 106,152,000Source | 107,354,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | — | 48,805,000Source |
| Gross ProfitUSD | — | — | 157,369,000Source | 161,049,000Source | 151,579,000Source | 157,382,000Source | 136,188,000Source | 140,331,000Source | 595,578,000Source | 634,463,000Source | 624,448,000Source | 625,294,000Source |
| Income (Loss) Attributable to Parent, before TaxUSD | — | — | 61,814,000Source | 80,154,000Source | 69,133,000Source | 71,663,000Source | 38,541,000Source | 61,777,000Source | 257,496,000Source | 284,189,000Source | 276,025,000Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | 237,057,000Source | 249,803,000Source | 239,405,000Source | -130,331,000Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | 1,800,000Source | 5,200,000Source | — |
| Interest Expense, DebtUSD | — | — | — | 11,455,000Source | — | 12,281,000Source | — | — | — | — | — | 69,164,000Source |
| Interest Income (Expense), NetUSD | — | — | -10,672,000Source | -11,455,000Source | -10,036,000Source | -12,281,000Source | — | -10,203,000Source | -42,339,000Source | -47,632,000Source | -67,160,000Source | — |
| Marketing and Advertising ExpenseUSD | — | — | 40,055,000Source | 37,945,000Source | 38,701,000Source | 41,409,000Source | 34,668,000Source | 34,937,000Source | 148,782,000Source | 155,723,000Source | 153,315,000Source | 145,061,000Source |
| Operating ExpensesUSD | — | — | 74,878,000Source | 69,087,000Source | 71,909,000Source | 73,043,000Source | 83,668,000Source | 68,575,000Source | 286,169,000Source | 297,688,000Source | 282,019,000Source | 647,709,000Source |
| Interest Income (Expense), Nonoperating, Net | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
Filing attachments
tm2620415d1_ex4-1.htm · 8-K · 2026-07-15
EX-4.1 2 tm2620415d1_ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 INDENTURE Dated as of July 15, 2026 Among PRESTIGE BRANDS, INC., as the Issuer, the Guarantors from time to time party hereto and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee 6.250% SENIOR NOTES DUE 2034 TABLE OF CONTENTS Page ARTICLE 1 definitions and incorporation by reference Section 1.01. Definitions 1 Section 1.02. Other Defin…
Read attachment ↗tm2618021d1_ex99-1.htm · 8-K · 2026-06-16
EX-99.1 2 tm2618021d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Prestige Consumer Healthcare Inc Completes Acquisition of Breathe Right ® TARRYTOWN, N.Y., June 15, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) (“Prestige”) today announced that it has closed the previously announced acquisition of the Breathe Right® brand and certain other brands. The closing was finalized pursuant to the terms of the asset purchase agreement, announced on March 20, 2026, under which Pre…
Read attachment ↗tm269430d1_ex99-1.htm · 8-K · 2026-03-20
EX-99.1 2 tm269430d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 M a r c h 2 0, 2 0 2 6 Announcement of Agreement to Acquire Breathe Right Exhibit 99.1 M A R C H 2 0 2 6 A C Q U I S I T I O N A N N O U N C E M E N T Safe Harbor Disclosure 2 This presentation contains certain “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements regarding the timing of the closing of the acquisition; the tax benefits from the acq…
Read attachment ↗tm269430d1_ex99-2.htm · 8-K · 2026-03-20
EX-99.2 3 tm269430d1_ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 Prestige Consumer Healthcare Announces Agreement to Acquire Breathe Right ®, the Leader in Nasal Strips Entered agreement to acquire a portfolio of brands with revenue of $200 million and EBITDA of $95 million Breathe Right is an iconic and category-leading brand with strong margins and cash flow generation ───────────────────────────────────────────────────────────────────── Acquisition reinforces Prestige’s long-term or…
Read attachment ↗tm251576d1_ex99-1.htm · 8-K · 2025-01-06
EX-99.1 2 tm251576d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Prestige Consumer Healthcare Inc. Expands CFO Christine Sacco’s Role to Include Chief Operating Officer Responsibilities TARRYTOWN, N.Y., Jan. 6, 2025 (GLOBE NEWSWIRE) - Prestige Consumer Healthcare Inc. (the “Company” or “Prestige”) (NYSE: PBH) today announced that Chief Financial Officer Christine Sacco’s responsibilities have been expanded to include the role of Chief Operating Officer, effective immediately. In this enhanced pos…
Read attachment ↗